Intellectual Property India Publishes Patent Application for Plga–poly(2-Oxazine) Implants For Controlled Dexamethasone Release In Cochlear Therapy

MUMBAI, India, Aug. 12 -- Intellectual Property India has published a patent application (202611076504 A) filed by Noida Institute Of Engineering And Technology Niet on June 20, 2026, for Plga–poly(2-Oxazine) Implants For Controlled Dexamethasone Release In Cochlear Therapy.

Inventors include Dr Swarupanjali Padhi; and Dr. Monika.

The application for the patent was published on August 07, 2026, under issue no. 32/2026.

Abstract: The present invention discloses biodegradable poly(lactic-co-glycolic acid) (PLGA) formulations comprising poly(2-alkyl-oxazine)s (POz) as plasticizers for controlled intracochlear release of dexamethasone. POz, being six-membered ring analogs of poly(2-oxazoline)s, offer enhanced backbone flexibility, lower glas...